10x Genomics Stock Technical Analysis
| TXG Stock | USD 21.08 0.54 2.50% |
As of the 29th of January, 10X Genomics shows the mean deviation of 3.34, and Coefficient Of Variation of 577.7. Compared to fundamental indicators, the technical analysis model gives you tools to check timely technical drivers of 10X Genomics, as well as the relationship between them. Please confirm 10X Genomics standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if 10X Genomics is priced more or less accurately, providing market reflects its regular price of 21.08 per share. Given that 10X Genomics has jensen alpha of 0.6788, we suggest you to validate 10X Genomics's prevailing market performance to make sure the company can sustain itself sooner or later.
10X Genomics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as 10X, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to 10X10X Genomics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.10X Genomics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 18.08 | Buy | 16 | Odds |
Most 10X analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand 10X stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of 10X Genomics, talking to its executives and customers, or listening to 10X conference calls.
Can Life Sciences Tools & Services industry sustain growth momentum? Does 10X have expansion opportunities? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating 10X Genomics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.63) | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets | Return On Equity |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, 10X Genomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
10X Genomics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 10X Genomics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 10X Genomics.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in 10X Genomics on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding 10X Genomics or generate 0.0% return on investment in 10X Genomics over 90 days. 10X Genomics is related to or competes with Schrodinger, Progyny, Guardian Pharmacy, Teladoc, Omada Health, Janux Therapeutics, and Omnicell. 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for ana... More
10X Genomics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 10X Genomics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 10X Genomics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.06 | |||
| Information Ratio | 0.1597 | |||
| Maximum Drawdown | 23.84 | |||
| Value At Risk | (3.91) | |||
| Potential Upside | 10.23 |
10X Genomics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 10X Genomics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 10X Genomics' standard deviation. In reality, there are many statistical measures that can use 10X Genomics historical prices to predict the future 10X Genomics' volatility.| Risk Adjusted Performance | 0.1341 | |||
| Jensen Alpha | 0.6788 | |||
| Total Risk Alpha | 0.4587 | |||
| Sortino Ratio | 0.2388 | |||
| Treynor Ratio | 0.3889 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 10X Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
10X Genomics January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1341 | |||
| Market Risk Adjusted Performance | 0.3989 | |||
| Mean Deviation | 3.34 | |||
| Semi Deviation | 2.54 | |||
| Downside Deviation | 3.06 | |||
| Coefficient Of Variation | 577.7 | |||
| Standard Deviation | 4.58 | |||
| Variance | 20.93 | |||
| Information Ratio | 0.1597 | |||
| Jensen Alpha | 0.6788 | |||
| Total Risk Alpha | 0.4587 | |||
| Sortino Ratio | 0.2388 | |||
| Treynor Ratio | 0.3889 | |||
| Maximum Drawdown | 23.84 | |||
| Value At Risk | (3.91) | |||
| Potential Upside | 10.23 | |||
| Downside Variance | 9.36 | |||
| Semi Variance | 6.43 | |||
| Expected Short fall | (3.94) | |||
| Skewness | 1.36 | |||
| Kurtosis | 2.17 |
10X Genomics Backtested Returns
10X Genomics appears to be not too volatile, given 3 months investment horizon. 10X Genomics secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18 % return per unit of risk over the last 3 months. By inspecting 10X Genomics' technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please makes use of 10X Genomics' coefficient of variation of 577.7, and Mean Deviation of 3.34 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, 10X Genomics holds a performance score of 14. The firm shows a Beta (market volatility) of 2.01, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 10X Genomics will likely underperform. Please check 10X Genomics' expected short fall, as well as the relationship between the rate of daily change and period momentum indicator , to make a quick decision on whether 10X Genomics' price patterns will revert.
Auto-correlation | 0.67 |
Good predictability
10X Genomics has good predictability. Overlapping area represents the amount of predictability between 10X Genomics time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 10X Genomics price movement. The serial correlation of 0.67 indicates that around 67.0% of current 10X Genomics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 6.36 |
10X Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
10X Genomics Technical Analysis
Indicator |
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of 10X Genomics volatility developed by Welles Wilder.
About 10X Genomics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of 10X Genomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of 10X Genomics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on 10X Genomics price pattern first instead of the macroeconomic environment surrounding 10X Genomics. By analyzing 10X Genomics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of 10X Genomics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to 10X Genomics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 13.31 | 15.21 | 13.69 | 14.37 | Days Of Inventory On Hand | 128.47 | 154.53 | 139.07 | 138.06 |
10X Genomics January 29, 2026 Technical Indicators
Most technical analysis of 10X help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for 10X from various momentum indicators to cycle indicators. When you analyze 10X charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1341 | |||
| Market Risk Adjusted Performance | 0.3989 | |||
| Mean Deviation | 3.34 | |||
| Semi Deviation | 2.54 | |||
| Downside Deviation | 3.06 | |||
| Coefficient Of Variation | 577.7 | |||
| Standard Deviation | 4.58 | |||
| Variance | 20.93 | |||
| Information Ratio | 0.1597 | |||
| Jensen Alpha | 0.6788 | |||
| Total Risk Alpha | 0.4587 | |||
| Sortino Ratio | 0.2388 | |||
| Treynor Ratio | 0.3889 | |||
| Maximum Drawdown | 23.84 | |||
| Value At Risk | (3.91) | |||
| Potential Upside | 10.23 | |||
| Downside Variance | 9.36 | |||
| Semi Variance | 6.43 | |||
| Expected Short fall | (3.94) | |||
| Skewness | 1.36 | |||
| Kurtosis | 2.17 |
10X Genomics January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as 10X stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | (0.90) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 21.30 | ||
| Day Typical Price | 21.23 | ||
| Price Action Indicator | (0.49) | ||
| Market Facilitation Index | 0.60 |
Complementary Tools for 10X Stock analysis
When running 10X Genomics' price analysis, check to measure 10X Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X Genomics is operating at the current time. Most of 10X Genomics' value examination focuses on studying past and present price action to predict the probability of 10X Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X Genomics' price. Additionally, you may evaluate how the addition of 10X Genomics to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |